| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.49 | 0.004 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |